Here’s whether Edwards Lifesciences Corp (EW) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.13% over 10 days); RSI 54 — healthy momentum range; strong 1-year return of +10.6%. Concerns: declining volume on rally — weak conviction (0.67x 30d avg). Currently 6.8% off its 52-week high. Score: +5/7.
EW is in a confirmed uptrend, trading above both its 50-day ($88.99) and 200-day ($84.65) moving averages. An RSI of 53.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +10.6% compares to +20.5% for SPY (trailed the market by 9.8%).
$10,000 invested 1 year ago→ $11,063 today
vs. S&P 500 (SPY) — same period trailed market by 9.8%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($84.65)
✓Above 50-day MA ($88.99)
✓RSI(14) neutral zone (30–70) — currently 53.8
✓Positive return (+10.6%)
✓Within 10% of period high (−6.8%)
Period Range $89.79
$72.30$96.29
RSI (14) 53.8
0 · OversoldOverbought · 100
Key Metrics
Price$89.79
Period Return+10.6%
Period High$96.29
Period Low$72.30
Drawdown−6.8%
MA-50$88.99
MA-200$84.65
RSI (14)53.8
Avg Volume (30d)4.4M
vs. SPYtrailed by 9.8%
Return Rank#481 of 999
Trend Signals
Price is above the 200-day moving average ($84.65)